In vivo potential antidiabetic activity of a novel zinc coordination compound based on 3-carboxy-pyrazole

J Inorg Biochem. 2014 Feb:131:64-7. doi: 10.1016/j.jinorgbio.2013.10.019. Epub 2013 Oct 30.

Abstract

A novel Zn mononuclear complex with 3-carboxy-pyrazole ligand has been prepared using conventional routes and characterized by X-ray diffraction. The structure consists of discrete neutral [Zn(C6H3N2O2)2(H2O)2] molecules held together by hydrogen interactions. This compound exhibits a potential in vivo antidiabetic activity and the in vitro toxicity can be considered negligible.

Keywords: Antidiabetic activity; Coordination compound; in vitro toxicity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Body Weight / drug effects
  • Diabetes Mellitus, Experimental / drug therapy
  • Eating / drug effects
  • Hypoglycemic Agents / chemical synthesis
  • Hypoglycemic Agents / chemistry*
  • Hypoglycemic Agents / pharmacology*
  • Male
  • Molecular Structure
  • Organometallic Compounds / chemical synthesis
  • Organometallic Compounds / chemistry*
  • Organometallic Compounds / pharmacokinetics*
  • Pyrazoles / chemistry
  • Rats
  • Rats, Wistar
  • X-Ray Diffraction
  • Zinc / chemistry*

Substances

  • Hypoglycemic Agents
  • Organometallic Compounds
  • Pyrazoles
  • pyrazole
  • Zinc